IPO Premiums
IPO calendar
IDListed

Invicta Diagnostic Limited

Bookbuilding IPO · NSE

Price band
₹80 - ₹85
Lot size
1,600 shares
Issue amount
₹28.12 cr
Total subscription
4.34×
Current price₹68.15
Listing price ₹100
Watch live price ↗
Opens
1 Dec 2025
Closes
3 Dec 2025
Allotment
4 Dec 2025
Listing
8 Dec 2025

Offer at a glance

Issue overview

Issue size
33,08,800 shares
Face value
₹10 per share
Minimum investment
₹1,28,000
Fresh issue
₹28.12 cr
Offer for sale
₹0 cr
Registrar
Bigshare Services Private Limited
Listing exchange
NSE
Maximum investment
₹1,36,000
Issue type
Bookbuilding IPO
Shares before issue
92,63,173
Shares after issue
1,25,71,973

Lot sizes

CategoryLotsSharesAmount
RETAIL23,200₹2,72,000
sHNI34,800₹4,08,000
bHNI812,800₹10,88,000

Share reservation

ANCHOR24.13%
QIB16.15%
HNI16.39%
RETAIL38.3%
Market Maker5.03%

Subscription & GMP

Subscription by category

Total subscribed4.34×

Reported 3 Dec 2025

QIB3.51×
NIB7.27×
RETAIL3.44×
HNIs(10L+)7.76×
HNIs(2-10L)6.27×

GMP history

00.5125 Nov: ₹026 Nov: ₹027 Nov: ₹028 Nov: ₹01 Dec: ₹02 Dec: ₹03 Dec: ₹0
25 Nov₹03 Dec

Day-wise demand

1 Dec0.54×
2 Dec1.03×
3 Dec4.34×

Application-wise demand

CategoryReserved applicationsApplied applications
QIB03
NIB0407
RETAIL3961,363
HNIs(10L +)75189
HNIs (2-10L)38218

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs4.5415.94
Others015.94
RETAIL10.7737.07
NIB4.6133.5
HNIs 2+1.549.64
HNIs 10+3.0723.85

Financial performance

Company financials

In Crores · Reported periods may include interim results.

Revenue & profit In Crores
010203040Mar-24 · Revenue: 15.9Mar-24 · Profit after tax: 3.81Mar-24Mar-25 · Revenue: 30.18Mar-25 · Profit after tax: 4.93Mar-25Sep-25 · Revenue: 17.08Sep-25 · Profit after tax: 4.08Sep-25
RevenueProfit after tax

Key performance indicators

MetricSep-25Mar-25Mar-24
EPS4.595.864.52
ROE21.9144.2855.53
ROCE22.84256.04
RONW000
PRE IPO(PE)015.970
POST IPO(PE)13.0800

Values and labels as reported in the issue data.

Peer comparison

CompanyP/E(X)CMP* (₹)Face value (₹)NAV/Share (₹)RONW(%)EPS (Basic) (₹)
Invicta Diagnostic Limited15.97010.0016.1536.255.86
Vijaya Diagnostic Centre Limited72.221007.41.0077.8617.9913.95
Krsnaa Diagnostics Limited34.39826.85.00272.548.7924.04

Company information

Company profile

Incorporated in January 2021, Invicta Diagnostic Limited (operating as PC Diagnostics) is a Mumbai-based diagnostic services provider offering integrated radiology and pathology solutions through a hub-and-spoke model spread across the Mumbai Metropolitan Region, comprising a flagship advanced diagnostic hub in Thane West, three additional hubs in Bhayandar, Byculla, and Marol, and four spokes focused on basic imaging and sample collection; the company provides around 60 routine and 487 specialised pathology tests along with 96 basic and 130 advanced radiology tests, supported by a strong home-collection network and a team of 5 laboratory doctors, 20 radiologists, 127 technical staff, and 105 permanent employees as of May 31, 2025.

Strengths

  • Expanding Footprint Across Mumbai Metropolitan Region: Rapid growth from one centre in 2021 to seven multi-format diagnostic facilities (hubs, spokes, and a central lab) enhances accessibility and strengthens market presence.
  • Comprehensive & Affordable Diagnostic Services: A one-stop offering of pathology and radiology solutions delivers convenience, faster diagnostics, and cost-effective care for patients under the “PC Diagnostics” brand.
  • Advanced Technology & Skilled Medical Team: Modern imaging infrastructure including CT, MRI, and PET CT systems supported by experienced radiologists ensures accurate, high-quality, and efficient diagnostic outcomes.

Risk factors

  • High Sensitivity to Brand Image & Patient Experience: Heavy reliance on walk-in customers means even small lapses in service quality, test accuracy, or turnaround time can damage reputation and impact revenue growth.
  • Operational Dependence on Flagship Thane Centre: Centralized processing of majority tests at one key facility exposes the business to major disruptions in case of equipment failure, regulatory issues, or unforeseen events.
  • Geographic Concentration Risk in MMR: Entire revenue comes from the Mumbai Metropolitan Region, making performance highly vulnerable to regional economic, policy, or healthcare disruptions.

Promoters

Dr. Ketan Jayantilal Jain

Dr. Sanket Vinod Jain

Rohit Prakash Srivastava

Badal Kailash Naredi

Jayesh Prakash Jain

Registrar & documents

Lead manager

Socradamus Capital Private Limited

Registered office

1 GF, Plot 217, Ambavat Bhavan N.M Joshi Marg Delisle Road Mumbai, Maharashtra, 400013

022 - 4971 0036

[email protected]Company website ↗

Frequently Asked Questions

What is Invicta Diagnostic IPO GMP today?

Currently, Invicta Diagnostic IPO Grey Market Premium (GMP) is trading around ₹0 or awaiting active buyer-seller quotes in the grey market. The issue price is set at ₹85. Track daily updates on IPO Premiums as bidding numbers unfold.

What is the lot size and minimum investment for Invicta Diagnostic IPO?

The minimum bid lot size for Invicta Diagnostic IPO is 1,600 shares. At the cut-off price of ₹85 per share, retail investors need a minimum application amount of ₹1,36,000 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).

When will Invicta Diagnostic IPO allotment status be announced?

The allotment status for Invicta Diagnostic IPO is scheduled to be finalized on 4 Dec 2025. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Bigshare Services Private Limited's official portal or via BSE/NSE allotment portals.

How can I check Invicta Diagnostic IPO allotment status online by PAN?

To check Invicta Diagnostic IPO allotment status: 1) Visit the registrar portal (Bigshare Services Private Limited) or the BSE IPO allotment page. 2) Select 'Invicta Diagnostic Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.

Explore More IPO Analysis & Live Tools

Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.

Regulatory Disclaimer: Grey Market Premium (GMP) is an unofficial, unregulated indicator of market sentiment and does not represent a stock exchange transaction, guarantee, or investment advice. IPO Premiums is an informational and research portal and is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before applying for any IPO.
Invicta Diagnostic IPO GMP Today, Subscription Status & Allotment Date | IPO Premiums